Health
First human trial of leading vaccine candidate shows promise – Health24
A vaccine being developed by AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results
- Among leading vaccine candidates in development
- Minor side effects with some patients, but no adverse effects
- Company says it won’t seek profit from the vaccine
AstraZeneca’s experimental Covid-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.
The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious s…
-
General20 hours agoVote counting begins for Townsville mayoral by-election
-
General22 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
Business12 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI
-
Business10 hours ago3 US dividend stocks that can boost an ASX retirement portfolio